STEX
Get informed when a big investor buys or sells
+ FollowOvervalued by 134.5% based on the discounted cash flow analysis.
| Market cap | $191.13 Million |
|---|---|
| Enterprise Value | $184.27 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-9.65 |
| Beta | 1.58 |
| Outstanding Shares | 47,966,169 |
| P/E Ratio | -0.14 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | 0.36 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.35 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
BioSig Technologies, Inc. recently rebranded as Streamex Corp., effective September 12, 2025, following its merger with Streamex Exchange Corporation. The company shifted focus from healthcare technology to real-world asset tokenization,...